1,360 Shares in Centene Co. (NYSE:CNC) Purchased by R Squared Ltd

R Squared Ltd bought a new stake in Centene Co. (NYSE:CNC) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,360 shares of the company’s stock, valued at approximately $82,000.

Other hedge funds have also made changes to their positions in the company. Park Place Capital Corp increased its stake in Centene by 1,190.0% in the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after buying an additional 357 shares during the period. Private Trust Co. NA raised its holdings in shares of Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock worth $58,000 after acquiring an additional 332 shares in the last quarter. True Wealth Design LLC purchased a new position in Centene in the third quarter valued at about $66,000. Venturi Wealth Management LLC increased its position in Centene by 77.3% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after purchasing an additional 507 shares during the last quarter. Finally, Cromwell Holdings LLC lifted its holdings in shares of Centene by 588.0% during the 3rd quarter. Cromwell Holdings LLC now owns 1,266 shares of the company’s stock valued at $95,000 after buying an additional 1,082 shares during the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.

Centene Stock Down 1.1 %

Shares of CNC opened at $63.93 on Friday. Centene Co. has a 52 week low of $55.03 and a 52 week high of $81.42. The firm has a market capitalization of $32.28 billion, a P/E ratio of 11.10, a P/E/G ratio of 0.85 and a beta of 0.45. The company has a 50-day simple moving average of $61.10 and a 200-day simple moving average of $67.17. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10.

Wall Street Analyst Weigh In

CNC has been the topic of several recent research reports. Truist Financial cut their price objective on shares of Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a research report on Friday, December 13th. Barclays upped their price objective on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and raised their target price for the company from $79.00 to $80.00 in a report on Friday, December 13th. Oppenheimer lowered their price objective on Centene from $95.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, December 13th. Finally, Stephens reduced their target price on Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a report on Friday, December 13th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.92.

Insider Buying and Selling at Centene

In other Centene news, CFO Andrew Lynn Asher bought 17,200 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were acquired at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the purchase, the chief financial officer now directly owns 486,847 shares in the company, valued at $28,305,284.58. The trade was a 3.66 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Thomas Greco purchased 17,000 shares of the business’s stock in a transaction on Wednesday, December 18th. The shares were acquired at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the purchase, the director now owns 19,309 shares of the company’s stock, valued at approximately $1,153,712.75. This trade represents a 736.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 45,010 shares of company stock valued at $2,660,276 in the last quarter. Corporate insiders own 0.33% of the company’s stock.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.